(Q36573831)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925487%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Use of autoantibodies in breast cancer screening and diagnosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925487%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

breast cancer screening

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925487%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Jayeta Chakrabarti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925487%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Anthony Barnes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925487%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Andrea Murray

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925487%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Caroline J Chapman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925487%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

John F R Robertson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925487%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925487%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anticancer Therapy

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925487%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925487%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925487%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1215-1223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925487%20AND%20SRC:MED&resulttype=core&format=json

Cancer burden in the year 2000. The global picture

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Global trends in breast cancer incidence and mortality 1973-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Status of mammography after the Digital Mammography Imaging Screening Trial: digital versus film

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Tumor markers in breast cancer- European Group on Tumor Markers recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Relative paradigms between autoantibodies in lupus and autoantibodies in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Autoantigen microarrays for multiplex characterization of autoantibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Human neoplasms elicit multiple specific immune responses in the autologous host

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Improved approach to identify cancer-associated autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

TP53 tumor suppressor gene: a model for investigating human mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

HER-2/neu signal transduction in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

HER-2/neu as a predictive marker of response to breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Detection of autoantibodies to survivin and livin in sera from patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

A new antigen on the epithelial membrane: its immunoperoxidase localisation in normal and neoplastic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

The relationship between serum p53 autoantibodies and characteristics of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

P53 autoantibodies in 1006 patients followed up for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

Phases of biomarker development for early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

The objective measurement of remission and progression in metastatic breast cancer by use of serum tumour markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1215

10.1586/14737140.6.8.1215

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925487%20AND%20SRC:MED&resulttype=core&format=json

release_3pno7dntxzamhikzqnbeg6c5am

29 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3pno7dntxzamhikzqnbeg6c5am

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference